Showing results (771-780 of 834) with videos related to
Sort By:
Pageof 84
MMWR. Morbidity and Mortality Weekly Report|May 15, 2020
Survival and HIV-Free Survival Among Children Aged ≤3 Years - Eight Sub-Saharan African Countries, 2015-2017Sasi Jonnalagadda, Katharine Yuengling, Elaine Abrams, et al.ESMO Open|July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14D König, S Savic Prince, S Hayoz, et al.Journal of the American Chemical Society|March 6, 2021
Allomelanin: A Biopolymer of Intrinsic MicroporosityNaneki C McCallum, Florencia A Son, Tristan D Clemons, et al.Neuro-Oncology|November 1, 2020
Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033Martin Klein, A Josephine Drijver, Martin J van den Bent, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 18, 2023
Dynamic and Assembly Characteristics of Deep-Cavity Basket Acting as a Host for Inclusion Complexation of Mitoxantrone in Biotic and Abiotic SystemsRadoslav Z Pavlović, Tyler J Finnegan, Anna Metlushko, et al.Oncogene|June 13, 2020
Ribosomal protein S11 influences glioma response to TOP2 poisonsChidiebere U Awah, Li Chen, Mukesh Bansal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trialMark R Gilbert, Meihua Wang, Kenneth D Aldape, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Glioblastoma Clinical Trials: Current Landscape and Opportunities for ImprovementStephen J Bagley, Shawn Kothari, Rifaquat Rahman, et al.Neuro-Oncology Advances|January 7, 2021
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modelingMarijke B Coomans, Linda Dirven, Neil K Aaronson, et al.Pageof 84